Effects of vitamin D receptor polymorphisms on the risk of schizophrenia and metabolic changes caused by risperidone treatment

Psychiatry Res. 2014 Mar 30;215(3):806-7. doi: 10.1016/j.psychres.2013.12.037. Epub 2013 Dec 31.

Authors

Pei Jiang¹, Man-Qin Zhu¹, Huan-De Li², Yi-Ping Liu¹, Hua-Lin Cai¹, Li-Ming Zhang¹

Affiliations

¹ Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, China.
² Institute of Clinical Pharmacy & Pharmacology, Second Xiangya Hospital, Central South University, Changsha, China. Electronic address: [email protected].

PMID: 24418047
DOI: 10.1016/j.psychres.2013.12.037

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Antipsychotic Agents / adverse effects
Antipsychotic Agents / blood
Antipsychotic Agents / therapeutic use*
Asian People / genetics
Case-Control Studies
China
Female
Humans
Male
Metabolic Syndrome / blood
Metabolic Syndrome / genetics
Polymorphism, Single Nucleotide / genetics*
Receptors, Calcitriol / genetics*
Risk
Risk Assessment
Risperidone / adverse effects
Risperidone / blood
Risperidone / therapeutic use*
Schizophrenia / blood
Schizophrenia / drug therapy*
Schizophrenia / genetics
Socioeconomic Factors
Young Adult

Substances

Antipsychotic Agents
Receptors, Calcitriol
Risperidone